logo-loader
NASDAQ:RXII

RXi Pharmaceuticals Corp

Receive alerts
Market:
NASDAQ
Market Cap:
£0.00
Price
£0.00
Change
0%
52 weeks high
0
52 weeks low
0

In brief

RXi Pharmaceuticals (Nasdaq: RXII) is a biopharmaceutical company pursuing the development and commercialization of novel treatments for human diseases using a technology called RNA interference (RNAi). RNAi was discovered by our co-founder, Dr. Craig Mello, who was awarded the 2006 Nobel Prize for his groundbreaking work in this area. By harnessing the power of RNAi, we believe that RXi Pharmaceuticals may be able to develop a new class of therapeutic products that could have a number of distinct advantages over today’s drugs.